Pharmacist-directed Sputnik v (GAM-COVID-VAC) surveillance program: A prospective observational study in Southern India

Mohammed Salim Karattuthodi*, Dilip Chandrasekher, Linu Mohan Panakkal, C. Shinu, Mohammed Salman, Megha, E. Muhammad Swabeeh, Mohamed Fasil, A. M. Mohammad, Monika Reji

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Abstract

The study underwent to evaluate the adverse events, the incidence of COVID-19 and the participant's attitude and perception towards the vaccine following Sputnik V administration through an active surveillance program. The prospective observational study was conducted four months in the Sputnik V vaccination center that enrolled 700 participants. Sociodemographic details, medical histories, COVID-19 incidences and adverse events following immunization (AEFI) of each sample were collected through face-to-face interviews and a telephonic feedback system. A self-prepared and validated questionnaire addressed their acceptances and perceptions towards the vaccination drive. Our study reported 42.1% of AEFIs after the first dose and 9.1% after the second. Fever, pain at the injection site, body pain, headache and fatigue were predominant, while dizziness and diarrhoea were rare. However, AEFIs were not influenced by the presence of comorbidities (p > 0.05). On the other hand, there were limited post immunization (1.8%) COVID-19 patients and that too with minor severity (p < 0.01). Our participants were overall satisfied with the Sputnik V immunization. However, those presented with AEFIs on the consecutive three days depicted slightly declined gratification (p < 0.05). Our pharmacist-directed surveillance program on Sputnik V showed fewer events of AEFIs and negligible occurrence of COVID19 following immunization. Moreover, the population had appreciable attitude and positive perceptions towards Sputnik V vaccination.

Original languageEnglish
Pages (from-to)509-517
Number of pages9
JournalJournal of Basic and Clinical Physiology and Pharmacology
Volume34
Issue number4
DOIs
Publication statusAccepted/In press - 2022

All Science Journal Classification (ASJC) codes

  • Physiology
  • Pharmacology
  • Drug Discovery

Fingerprint

Dive into the research topics of 'Pharmacist-directed Sputnik v (GAM-COVID-VAC) surveillance program: A prospective observational study in Southern India'. Together they form a unique fingerprint.

Cite this